Back to
UBS Group AG
TVRD5 quarters
Position history for
UBS Group AG's holdings in TVARDI THERAPEUTICS INC COM
Yes. Ubs holds 111,133 shares of TVRD (Tvardi Therapeutics), worth $211,153, as of its Q2 2026 13F filing. It increased the position by 60,679 shares (+120.3%) from Q1 2026. Ubs has held TVRD in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$211,153
Current Shares
111,133
Total Value Change
-$473,653
Total Shares Change
+81,780
Quarter-by-Quarter History
Other major holders of TVRD: VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC